Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04868539 · ClinicalTrials.gov registry record · NA
Influence of Nocturnal Light Exposure on the Impairment of Glucose Tolerance Induced by Chronic Sleep Restriction
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04868539 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 14 participants.
The verdict
NCT04868539, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This project is designed to test for the first time whether glucose metabolism is differentially impaired by sleep restriction with and without additional exposure to artificial light at night (ALAN).
Interventions
- OTHER Sleep Restriction with ALAN first, then Sleep Restriction without ALAN
- OTHER Sleep Restriction without ALAN first, then sleep restriction with ALAN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-03-15 |
| Est. Completion | 2024-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04868539
The ClinicalTrials.gov registry entry for NCT04868539 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sleep Restriction with ALAN first, then Sleep Restriction without ALAN is the first listed.
NCT04868539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04868539 about?
NCT04868539 is a clinical study titled "Influence of Nocturnal Light Exposure on the Impairment of Glucose Tolerance Induced by Chronic Sleep Restriction". This project is designed to test for the first time whether glucose metabolism is differentially impaired by sleep restriction with and without additional exposure to artificial light at night (ALAN).
What is the current status of trial NCT04868539?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2022-03-15. Estimated completion is 2024-05-30.
What interventions are being tested in trial NCT04868539?
The interventions under investigation include: Sleep Restriction with ALAN first, then Sleep Restriction without ALAN (OTHER), Sleep Restriction without ALAN first, then sleep restriction with ALAN (OTHER).
Who is sponsoring clinical trial NCT04868539?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.